Probiotics' anti-cancer potential recognised by French

French probiotics firm Institut Rosell-Lallemand said it has been
included in a new government initiative to pool research into
cancer prevention and treatment.

France has created 67 competitivity poles, including the new 'Cancer-Bio-Health' pole in the Midi-Pyrénées region, home to Lallemand's French headquarters.

The poles, designed to focus research resources, will share a total of €1.5 billion over three years.

The new Toulouse Canceropole will investigate cancer prevention, mainly through nutrition (including both health-promoting food and food safety), as well as treatment and patient management.

Valérie Delahaye-Sarraute, marketing director at Lallemand, said: "The originality of the Cancer-Bio-Health Competitivity Pole lies in its integrated approach, based not only on diagnostics and therapeutics but also on nutrition as a prominent prevention tool in the fight against cancer."

She noted that there is increasing scientific evidence to show that probiotics may play a role in the prevention and even treatment of some gut inflammatory diseases, which could be related to the onset of certain cancers.

Related news

Show more

Related products

show more

BB536 for optimal Gut health and beyond

BB536 for optimal Gut health and beyond

Content provided by Morinaga Milk Industry Co., Ltd. | 03-Oct-2024 | White Paper

Among the various probiotics strains available, Bifidobacterium longum BB536 stands out due to its well-documented safety, efficacy, and regulatory approvals....

Related suppliers

Follow us

Products

View more

Webinars